HIV is also known to increase the rates of recurrent TB disease after successful completion of treatment for a fi rst episode. [4] [5] [6] As a result of the impact of HIV, countries with high HIV prevalence have had a two-to fi ve-fold increase in annual TB case notifi cation rates over the last decade. 4,7 This increase in TB burden has adversely affected TB programmes and has strained available human and fi nancial resources at programme level. 4, 8 Observational cohort studies in a wide range of settings have demonstrated that antiretroviral treatment (ART), through immune reconstitution, is associated with a 54% to 92% reduction in TB incidence at the individual patient level and a halving of the risk of TB recurrence. 7,9-13 It logically follows that if a large proportion of HIV-positive individuals in high HIV prevalence settings are offered ART, the reduction in TB incidence at the individual patient level should also have a benefi cial impact on TB incidence and case notifi cation at the population level. However, empirical data on the impact of ART on TB case notifi cation at the community level are lacking. 7 Thyolo District in rural southern Malawi had a global and adult HIV prevalence of respectively 10% and 21% in 2007. 14 The district has been progressively scaling up HIV/AIDS (acquired immune-defi ciency syndrome) care and ART since 2003. The district achieved and sustained universal ART access from 2007 onwards (sustained access for at least 80% of those in need). 15, 16 We hypothesised that such a large scale-up and coverage of ART at the population level might have been associated with a decrease in district TB case notifi cations. We thus report on trends in new and recurrent TB case notifi cations at the
O B J E C T I V E : To report on the trends in new and recurrent tuberculosis (TB) case notifi cations in a rural district of Malawi that has embarked on large-scale rollout of antiretroviral treatment (ART). M E T H O D S
HUMAN IMMUNODEFICIENCY virus (HIV) promotes progression to active tuberculosis (TB) disease in both recently acquired and latent Mycobacterium tuberculosis infection. [1] [2] [3] HIV is the most powerful known risk factor for reactivation of latent M. tuberculosis, with up to 10% of infected individuals at risk of developing TB per year. 4 HIV is also known to increase the rates of recurrent TB disease after successful completion of treatment for a fi rst episode. [4] [5] [6] As a result of the impact of HIV, countries with high HIV prevalence have had a two-to fi ve-fold increase in annual TB case notifi cation rates over the last decade. 4, 7 This increase in TB burden has adversely affected TB programmes and has strained available human and fi nancial resources at programme level. 4, 8 Observational cohort studies in a wide range of settings have demonstrated that antiretroviral treatment (ART), through immune reconstitution, is associated with a 54% to 92% reduction in TB incidence at the individual patient level and a halving of the risk of TB recurrence. 7, [9] [10] [11] [12] [13] It logically follows that if a large proportion of HIV-positive individuals in high HIV prevalence settings are offered ART, the reduction in TB incidence at the individual patient level should also have a benefi cial impact on TB incidence and case notifi cation at the population level. However, empirical data on the impact of ART on TB case notifi cation at the community level are lacking. 7 Thyolo District in rural southern Malawi had a global and adult HIV prevalence of respectively 10% and 21% in 2007. 14 The district has been progressively scaling up HIV/AIDS (acquired immune-defi ciency syndrome) care and ART since 2003. The district achieved and sustained universal ART access from 2007 onwards (sustained access for at least 80% of those in need). 15, 16 We hypothesised that such a large scale-up and coverage of ART at the population level might have been associated with a decrease in district TB case notifi cations. We thus report on trends in new and recurrent TB case notifi cations at the For the purposes of this study, new TB cases include individuals starting TB treatment for the fi rst time with pulmonary (smear-positive or -negative) or extra-pulmonary TB (EPTB); recurrent TB includes relapse cases and the 'other' category.
METHODS

Study setting and population
Data collection and statistical analysis
Cumulative data on annual TB case notifi cations were obtained from the district TB register for the period 2002-2009. TB case notifi cation was standardised per 100 000 population per year. Yearly district population data were based on national demographic health surveys (DHS) and census data. 21 The total numbers of individuals ever enrolled in HIV/AIDS care and ART on an annual basis were derived from the FUCHIA database (Follow-Up and Care of HIV Infection and AIDS [FUCHIA] , Epicentre, Paris, France) and the routine district reporting system.
The χ 2 test for trend was used to test for linear trends. The level of signifi cance was set at P ⩽ 0.05, and 95% confi dence intervals (CIs) were used throughout. Data were analysed using Microsoft Excel (Microsoft, Redmonds, WA, USA) and STATA 8.0 software (Stata Corporation, College Station, TX, USA).
Ethics clearance
The TB and ART programmes in Thyolo are implemented in close collaboration with the MoH of Malawi, in line with existing national guidelines. The study received ethics clearance from the ethics review boards of MSF and the International Union Against Tuberculosis and Lung Disease.
RESULTS
Characteristics of the study population
Over the study period (2002-2009) there were a total of 10 070 newly registered TB cases, comprising 4116 cases of smear-positive pulmonary TB (PTB), 3445 cases of smear-negative PTB and 2509 cases of EPTB. A total of 755 cases of recurrent TB were also reported, including 406 relapses and 349 in the 'other' category (Table 1) . Table 2 For new cases of TB, there was an initial increase in case notifi cations in the fi rst years after starting 2002  459  352  309  1 120  37  0  37  2003  464  315  282  1 061  49  33  82  2004  591  428  346  1 365  58  40  98  2005  580  500  365  1 445  73  60 113  2006  554  608  308  1 470  63  53 116  2007  545  497  306  1 348  48  56 104  2008  471  387  313  1 171  40  48  88  2009  452  358  280  1 090  38  59  97   Total 4116  3445  2509  10 070  406  349 755 TB = tuberculosis; PTB = pulmonary TB; EPTB = extra-pulmonary TB. (Table 3) .
Trend in TB case notifi cation and relation to enrolment in HIV/AIDS care and ART
DISCUSSION
In a rural district of Malawi that has embarked on scaling up ART, there appears to be a highly significant declining trend in TB case notifi cation. This is also one of the fi rst reports using routinely collected data showing the benefi cial impact of high ART coverage on TB case notifi cation at the community level. The benefi t is apparent for both new and recurrent cases of TB.
A number of observations merit discussion. First, an initial increase in TB case notifi cation in the early years of initiating ART is followed by a decline. Although we cannot be certain, the initial increase may be related to better TB case detection through scaleup of ART services: 22 TB suspects being enrolled into HIV care and not dying before their TB manifests, immune reconstitution unmasking TB in patients on ART, 23 or a rise in TB incidence due to low proportions of the HIV-positive (susceptible) population receiving ART. The comprehensive support activities provided by MSF in the district from 1999 onwards, particularly in providing new TB infrastructure, human resources and consumables for the district laboratory, drug support to all peripheral health facilities, HIV testing, cotrimoxazole prophylaxis and management of opportunistic infections, 17 are all likely to have brought more ill patients into the health system and contributed to improved referrals and diagnosis of TB suspects. Furthermore, support for community TB-HIV-related activities, including screening and referral of TB suspects, would have contributed to enhanced case fi nding. 24 Second, there is a progressive and highly significant declining trend in TB case notifi cation from 2005 onwards associated with ART scale-up and increased access to ART services at peripheral health facilities. Although we cannot know with certainty whether or not the observed reduction is linked to the ART roll-out, the association between the two is suggestive and intuitive. In a high HIV prevalence country such as Malawi, high TB incidence in the HIV-positive population is likely to be a very important contributor to community TB prevalence and transmission. 7 A reduction in TB risk conferred by the 'ART protective effect' in this highly susceptible subgroup 9-13 should therefore reduce TB incidence, and subsequently case notifi cation, at the population level. However, trends in case notifi cation in a given setting could be confounded by variables such as high mortality prior to TB diagnosis, changes in the efficiency of TB case detection, the improving socioeconomic status of the population or isoniazid preventive treatment (IPT) for HIV-positive individuals. 25 However, we do not believe that any of these factors would have contributed to the declining trends observed from 2005 onwards in our setting.
HIV care and ART scale-up were achieved and sustained by decentralising these services 15, 16 and, since 2006, increasing numbers of health facilities have also benefi ted from an increase in decentralised laboratory capability for diagnosing TB. By the end of 2009, sputum samples could be examined in seven microscopy sites, and an additional eight sites were able to perform full preparation (smearing and fi xation) of slides for reading. 26 Fluorescent microscopy has also been introduced at the district level to cope with the high caseloads of sputum samples and to increase diagnostic effi ciency. In other words, the decreasing trend in TB case notifi cations happened despite these efforts to enhance TB detection. Furthermore, there has been no implementation of IPT in the district, and we do not believe that there have been signifi cant improvements in social conditions such as employment opportunities or the earning capacity of the population. The prices of petrol, diesel and paraffi n have generally shown an upward trend over the study period, with a consequent increase in consumer prices. 27 The situation from 2005 onwards is therefore likely to represent the overall impact of ART on TB case notifi cation.
The strengths of this study are that TB case notification data for an entire district of more than half a million inhabitants were included and that the diagnosis and reporting systems for TB notifi cation and ART scale-up are standardised and supervised. The fi ndings are thus likely to refl ect the reality on the ground. The main limitation of the study is that it is based on simple observational data with the usual related shortcomings, and we are thus unable to demonstrate a cause-effect relationship. We therefore deliberately concentrated on general 'trend analysis' of case notifi cation, which is considered a proxy indicator of community TB incidence and prevalence.
Whatever the exact reasons for the decline, a reversal in the trend of TB case notifi cation associated with high ART coverage is very encouraging, as it brings some optimism towards achieving the United Nations Millennium Development Goal (MDG) targets, 28 where TB control is crucial. 29 In addition, it reduces the TB caseload burden in an overburdened health system facing severe shortages of human resources for health. The benefi cial effect on TB case notifi cation seen in this context is likely to be accentuated with recent WHO guidelines recommending starting ART at higher CD4 counts compared with Declining TB case rates with ART 937 during the period of this study. 30 There is now a need to further increase impetus in this direction through the implementation of the '3 Is', i.e., intensifi ed case fi nding, improved TB infection control and IPT. 31 Finally, this study provides important and encouraging evidence for donors on the population impact of ART coverage and advocates for continued involvement in ART and TB programmes in similar settings. On the other hand, a retreat from investment in such programmes could be disastrous to sustaining gains such as those described in this article.
In a rural district of Malawi that has achieved high ART coverage, there is very encouraging evidence of a signifi cant decline in TB case notifi cation rates for both new and recurrent TB at the population level. 
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